Besides the ROS induction and capability of disrupting intracellular iron metabolism, the anticancer activity of pharmacological ascorbate includes its modulation of SVCT2 activity by adding Mg2+, acting on tumor stem cells, and modulating epigenetics due to a hormetic response [25,193,291]. Here, SLC23A2 is linked to neoplasm.